Add to ORKG41st FEBS Congress on Molecular and Systems Biology for a Better Life -- SEP 03-08, 2016 -- Kusadasi, TURKEYWOS: 000383616901496FEB
PBS, phosphate buffer saline; OSOM, outer stripe of outer medulla; TUNEL, terminal deoxynucleotidyl ...
ABSTRACT Background Treatment with selective vitamin D receptor activators such as paricalcitol have...
Objectives: to determine the role of matrix metalloproteinases, MMP-2 and MMP-9, in reperfusion inju...
WOS: 000418444200002PubMed ID: 28737133Background: Ischemia-reperfusion injury (IRI) is a leading ca...
Objective: This study aimed to investigate the renoprotective effects of paricalcitol, a synhetic vi...
Objective: This study aimed to investigate the renoprotective effects of paricalcitol, a synhetic vi...
Contrast-induced acute kidney injury (CI-AKI) is the third most common cause of hospital-acquired re...
The protective mechanism of paricalcitol remains unclear in renal ischemia-reperfusion (IR) injury. ...
Despite its benefits, the clinical use of cyclosporine A (CsA) is limited by its nephrotoxic propert...
4-Hydroxy-2-hexenal (HHE), the aldehyde product of lipid peroxidation, may be responsible for the pa...
Background/Aims Indoxyl sulfate (IS) is a uremic toxin and an important causative factor in the prog...
4-Hydroxy-2-hexenal (HHE), the aldehyde product of lipid peroxidation, may be responsible for the pa...
PubMed ID: 28118507Aim: Matrix metalloproteinases (MMPs) are zinc-containing proteinases that are in...
AimMatrix metalloproteinases (MMPs) are zinc-containing proteinases that are involved in the degrada...
Vitamin D slows the progression of chronic kidney disease. Furthermore, activators of vitamin D rece...
PBS, phosphate buffer saline; OSOM, outer stripe of outer medulla; TUNEL, terminal deoxynucleotidyl ...
ABSTRACT Background Treatment with selective vitamin D receptor activators such as paricalcitol have...
Objectives: to determine the role of matrix metalloproteinases, MMP-2 and MMP-9, in reperfusion inju...
WOS: 000418444200002PubMed ID: 28737133Background: Ischemia-reperfusion injury (IRI) is a leading ca...
Objective: This study aimed to investigate the renoprotective effects of paricalcitol, a synhetic vi...
Objective: This study aimed to investigate the renoprotective effects of paricalcitol, a synhetic vi...
Contrast-induced acute kidney injury (CI-AKI) is the third most common cause of hospital-acquired re...
The protective mechanism of paricalcitol remains unclear in renal ischemia-reperfusion (IR) injury. ...
Despite its benefits, the clinical use of cyclosporine A (CsA) is limited by its nephrotoxic propert...
4-Hydroxy-2-hexenal (HHE), the aldehyde product of lipid peroxidation, may be responsible for the pa...
Background/Aims Indoxyl sulfate (IS) is a uremic toxin and an important causative factor in the prog...
4-Hydroxy-2-hexenal (HHE), the aldehyde product of lipid peroxidation, may be responsible for the pa...
PubMed ID: 28118507Aim: Matrix metalloproteinases (MMPs) are zinc-containing proteinases that are in...
AimMatrix metalloproteinases (MMPs) are zinc-containing proteinases that are involved in the degrada...
Vitamin D slows the progression of chronic kidney disease. Furthermore, activators of vitamin D rece...
PBS, phosphate buffer saline; OSOM, outer stripe of outer medulla; TUNEL, terminal deoxynucleotidyl ...
ABSTRACT Background Treatment with selective vitamin D receptor activators such as paricalcitol have...
Objectives: to determine the role of matrix metalloproteinases, MMP-2 and MMP-9, in reperfusion inju...